N4 Pharma PLC Financial Flexibility Index
N4 Pharma PLC financial flexibility index. N4 Pharma PLC (N4P) has a Financial Flexibility Index of -5.67x as of June 2025. Free cash flow of GBX-444.36K (operating CF GBX-444.37K minus capex GBX3.00) represents -6% of total liabilities (GBX78.37K). See N4P cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of N4 Pharma PLC (1991–2024)
Financial flexibility index of N4 Pharma PLC from 1991 to 2024. Historical Financial Flexibility Index trend for N4 Pharma PLC across 34 annual periods. Check N4 Pharma PLC (N4P) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
N4 Pharma PLC Financial Flexibility Index by Year (1991–2024)
N4 Pharma PLC financial flexibility index by year from 1991 to 2024. Year-by-year free cash flow to debt coverage for N4 Pharma PLC. For the full cash flow conversion analysis, see N4 Pharma PLC cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.81x | GBX-971.50K | GBX-971.50K | GBX124.37K | ▲ +47.2% |
| 2023 | -14.79x | GBX-1.21 Million | GBX-1.21 Million | GBX81.73K | ▼ -39.1% |
| 2022 | -10.63x | GBX-828.26K | GBX-828.26K | GBX77.89K | ▼ -27.6% |
| 2021 | -8.33x | GBX-1.77 Million | GBX-1.77 Million | GBX212.73K | ▼ -2.1% |
| 2020 | -8.16x | GBX-1.38 Million | GBX-1.38 Million | GBX169.08K | ▲ +21.4% |
| 2019 | -10.38x | GBX-806.00K | GBX-806.00K | GBX77.68K | ▼ -46.7% |
| 2018 | -7.07x | GBX-1.34 Million | GBX-1.34 Million | GBX190.12K | ▼ -33.3% |
| 2017 | -5.31x | GBX-950.80K | GBX-950.80K | GBX179.22K | ▼ -8.6% |
| 2016 | -4.88x | GBX-376.00K | GBX-376.00K | GBX77.00K | ▲ +90.4% |
| 2015 | -50.71x | GBX-862.00K | GBX-862.00K | GBX17.00K | ▼ -11935.2% |
| 2014 | -0.42x | GBX-340.00K | GBX-340.00K | GBX807.00K | ▼ -394.6% |
| 2013 | 0.14x | GBX129.00K | GBX-87.00K | GBX902.00K | ▲ +309.1% |
| 2012 | -0.07x | GBX-85.00K | GBX-324.00K | GBX1.24 Million | ▼ -104.3% |
| 2011 | 1.57x | GBX2.31 Million | GBX996.00K | GBX1.47 Million | ▲ +127.0% |
| 2010 | 0.69x | GBX718.00K | GBX249.00K | GBX1.04 Million | ▼ -52.2% |
| 2009 | 1.45x | GBX1.68 Million | GBX755.00K | GBX1.16 Million | ▲ +97.0% |
| 2008 | 0.74x | GBX408.00K | GBX-184.00K | GBX554.00K | ▲ +131.0% |
| 2007 | 0.32x | GBX169.00K | GBX160.00K | GBX530.00K | ▲ +505.8% |
| 2006 | -0.08x | GBX-40.00K | GBX-67.00K | GBX509.00K | ▼ -189.6% |
| 2005 | -0.03x | GBX-105.00K | GBX-113.00K | GBX3.87 Million | ▼ -154.4% |
| 2004 | 0.05x | GBX203.00K | GBX140.00K | GBX4.07 Million | ▲ +8.9% |
| 2003 | 0.05x | GBX216.00K | GBX85.00K | GBX4.71 Million | ▲ +130.1% |
| 2002 | -0.15x | GBX-738.00K | GBX-739.00K | GBX4.85 Million | ▼ -447.4% |
| 2001 | 0.04x | GBX228.00K | GBX210.00K | GBX5.21 Million | ▲ +254.2% |
| 2000 | -0.03x | GBX-228.00K | GBX-380.00K | GBX8.03 Million | ▼ -155.6% |
| 1999 | -0.01x | GBX-97.00K | GBX-171.00K | GBX8.73 Million | ▲ +95.8% |
| 1998 | -0.26x | GBX-2.66 Million | GBX-2.72 Million | GBX10.10 Million | ▼ -541.7% |
| 1997 | -0.04x | GBX-1.07 Million | GBX-2.66 Million | GBX26.17 Million | ▼ -117.0% |
| 1996 | 0.24x | GBX5.69 Million | GBX2.02 Million | GBX23.55 Million | ▲ +48.9% |
| 1995 | 0.16x | GBX4.09 Million | GBX163.00K | GBX25.21 Million | ▼ -49.6% |
| 1994 | 0.32x | GBX6.07 Million | GBX3.34 Million | GBX18.88 Million | ▲ +244.2% |
| 1993 | 0.09x | GBX1.13 Million | GBX310.00K | GBX12.14 Million | ▼ -49.2% |
| 1992 | 0.18x | GBX3.35 Million | GBX2.72 Million | GBX18.22 Million | ▲ +306.8% |
| 1991 | -0.09x | GBX-1.78 Million | GBX-2.42 Million | GBX20.05 Million | — |